Eosinophiles solide und zystisches Nierenzellkarzinom (ESC-NZK)
暂无分享,去创建一个
[1] A. Sangoi,et al. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases , 2021, Modern Pathology.
[2] M. Tretiakova,et al. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia, but without clinical features of tuberous sclerosis complex. , 2021, Human pathology.
[3] J. Cheville,et al. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.
[4] T. Antic,et al. Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous , 2020, The American journal of surgical pathology.
[5] A. Caliò,et al. Eosinophilic Solid and Cystic Renal Cell Carcinoma , 2019, Encyclopedia of Pathology.
[6] V. Reuter,et al. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm , 2019, The American journal of surgical pathology.
[7] S. Dhanasekaran,et al. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. , 2018, European urology.
[8] M. Bonert,et al. “High-grade oncocytic renal tumor”: morphologic, immunohistochemical, and molecular genetic study of 14 cases , 2018, Virchows Archiv.
[9] P. Argani,et al. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum , 2018, The American journal of surgical pathology.
[10] Lauren L. Ritterhouse,et al. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? , 2018, The American journal of surgical pathology.
[11] M. Tretiakova. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases. , 2018, Human pathology.
[12] P. Argani,et al. Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients , 2018, Histopathology.
[13] J. McKenney,et al. Eosinophilic solid and cystic renal cell carcinomas have metastatic potential , 2018, Histopathology.
[14] Yingbei Chen,et al. A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma , 2017, Histopathology.
[15] D. Berney,et al. Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity , 2017, The American journal of surgical pathology.
[16] A. Sangoi,et al. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women , 2016, The American journal of surgical pathology.
[17] J. McKenney,et al. Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity , 2014, The American journal of surgical pathology.
[18] A. Sangoi,et al. Tuberous Sclerosis–associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients , 2014, The American journal of surgical pathology.
[19] J. Bernstein. Renal cystic disease in the tuberous sclerosis complex , 1993, Pediatric Nephrology.